Mangalam Drugs and Organics Limited announced key management changes following a Board of Directors meeting held on February 6, 2026. The board accepted the resignation of Shri Rukmesh P. Dhandhania as an Independent Director, effective January 16, 2026. He decided to resign to retire from his professional responsibilities. In a significant move, the company appointed Mr. Jeevan M. Dalvi as its new Chief Financial Officer (CFO), effective February 6, 2026. Mr. Dalvi, a Commerce graduate, brings over two decades of experience in accounts and finance, with expertise in financial advisory, cost-saving measures, and improving financial processes. Furthermore, the board approved the re-appointment of Dr. Praveen Saxena as an Independent Director for a second term of five years. This re-appointment is scheduled from March 21, 2026, to March 20, 2031, and is subject to shareholders' approval via a Special Resolution. Dr. Saxena is an international expert in energy policy and renewable energy development.
